Logo image of NCI

NEO-CONCEPT INTL GROUP HLDNG (NCI) Stock Fundamental Analysis

NASDAQ:NCI - Nasdaq - KYG6421C1042 - Common Stock - Currency: USD

0.5003  +0.01 (+1.65%)

Premarket: 0.4847 -0.02 (-3.12%)

Fundamental Rating

1

Taking everything into account, NCI scores 1 out of 10 in our fundamental rating. NCI was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of NCI have multiple concerns. NCI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NCI had positive earnings in the past year.
NCI had a negative operating cash flow in the past year.
NCI Yearly Net Income VS EBIT VS OCF VS FCFNCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M

1.2 Ratios

NCI's Return On Assets of -0.84% is in line compared to the rest of the industry. NCI outperforms 40.82% of its industry peers.
NCI has a better Return On Invested Capital (27.88%) than 95.92% of its industry peers.
Industry RankSector Rank
ROA -0.84%
ROE N/A
ROIC 27.88%
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI Yearly ROA, ROE, ROICNCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -50 -100 -150

1.3 Margins

NCI has a Operating Margin of 2.92%. This is in the lower half of the industry: NCI underperforms 63.27% of its industry peers.
NCI has a Gross Margin of 18.73%. This is amonst the worse of the industry: NCI underperforms 89.80% of its industry peers.
Industry RankSector Rank
OM 2.92%
PM (TTM) N/A
GM 18.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCI Yearly Profit, Operating, Gross MarginsNCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NCI is creating value.
Compared to 1 year ago, NCI has about the same amount of shares outstanding.
The debt/assets ratio for NCI has been reduced compared to a year ago.
NCI Yearly Shares OutstandingNCI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
NCI Yearly Total Debt VS Total AssetsNCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.59 indicates that NCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of NCI (2.59) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACC2.48
WACC11.22%
NCI Yearly LT Debt VS Equity VS FCFNCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -20M -40M -60M

2.3 Liquidity

A Current Ratio of 0.91 indicates that NCI may have some problems paying its short term obligations.
NCI has a worse Current ratio (0.91) than 95.92% of its industry peers.
NCI has a Quick Ratio of 0.91. This is a bad value and indicates that NCI is not financially healthy enough and could expect problems in meeting its short term obligations.
NCI has a worse Quick ratio (0.84) than 75.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.84
NCI Yearly Current Assets VS Current LiabilitesNCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

NCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.84%.
NCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.41%.
EPS 1Y (TTM)-17.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%129.34%
Revenue 1Y (TTM)-40.41%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCI Yearly Revenue VS EstimatesNCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100M 200M 300M
NCI Yearly EPS VS EstimatesNCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.51, the valuation of NCI can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 83.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 30.30, NCI is valued rather cheaply.
Industry RankSector Rank
PE 12.51
Fwd PE N/A
NCI Price Earnings VS Forward Price EarningsNCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NCI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.04
NCI Per share dataNCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEO-CONCEPT INTL GROUP HLDNG

NASDAQ:NCI (2/20/2025, 8:00:01 PM)

Premarket: 0.4847 -0.02 (-3.12%)

0.5003

+0.01 (+1.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.49%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner Change0%
Market Cap10.34M
Analysts60
Price TargetN/A
Short Float %1.54%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.51
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14.04
EPS(TTM)0.04
EY8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.57
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE N/A
ROCE 35.39%
ROIC 27.88%
ROICexc 38.79%
ROICexgc 38.79%
OM 2.92%
PM (TTM) N/A
GM 18.73%
FCFM N/A
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 879.05%
Cap/Sales 0.51%
Interest Coverage 1.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.84
Altman-Z 2.59
F-Score3
WACC11.22%
ROIC/WACC2.48
Cap/Depr(3y)318.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%129.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.41%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.12%
OCF growth 3YN/A
OCF growth 5YN/A